Stephenson Cancer Center - Tulsa Location
Tulsa, Oklahoma, 74104, United States
NCT Number: NCT07742449
This project will evaluate the feasibility and acceptability of Empowered Relief (ER) among American Indian adults who are currently receiving or have completed active cancer treatments at Stephenson Cancer Center (SCC). ER is a single-session, Zoom-based, 2-hour, skills-based pain management class delivered by certified instructors. Participants learn three core pain relief skills, develop a personalized plan, and receive access to a free binaural audio app for daily practice. ER has demonstrated moderate efficacy in individuals with chronic non-cancer pain, reducing pain intensity, pain interference, pain-related distress (pain catastrophizing), sleep disturbance, and anxiety at 3 and 6 months post-treatment. Because of its brief, didactic nature and Zoom delivery, ER can accommodate large class sizes and may address accessibility disparities among underserved cancer populations. While ER is being studied across various non-cancer populations and has been adopted as standard of care in leading healthcare institutions in the U.S. and abroad, it has not been tested in American Indians with cancer.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Tulsa, Oklahoma, 74104, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ER is a single-session, Zoom-based, 2-hour, skills-based pain management class delivered by certified instructors. Participants learn three core pain relief skills, develop a personalized plan, and receive access to a free binaural audio app for daily practice. ER has demonstrated moderate efficacy in individuals with chronic non-cancer pain, reducing pain intensity, pain interference, pain-related distress (pain catastrophizing), sleep disturbance, and anxiety at 3 and 6 months post-treatment.
Time frame: From participant accrual to the completion of their 3-mon follow up survey (approx. 4 months)
Indexed by:
Time frame: Assessed as part of the optional (n=30) Qualitative Post-class interview. (approx. 30 minutes)
We will use qualitative data from interviews to generate actionable recommendations to improve the cultural engagement, acceptability, and relevance of ER for American Indians with cancer.
Time frame: Data collected at the 1-, 2-, and 3-month follow up survey following the ER class
Pilot data on clinical outcomes to estimate effect sizes and inform power calculations for a fully powered randomized trial. These measures will be collected using a series of verified survey questionnaires.
Time frame: Data collected at the 1-, 2-, and 3-month follow up survey following the ER class.
Pilot data on clinical outcomes to estimate effect sizes and inform power calculations for a fully powered randomized trial. These measures will be collected using a series of verified survey questionnaires.
Time frame: Data collected at the 1-, 2-, and 3-month follow up survey following the ER class.
Pilot data on clinical outcomes to estimate effect sizes and inform power calculations for a fully powered randomized trial. These measures will be collected using a series of verified survey questionnaires.
Time frame: Data collected at the 1-, 2-, and 3-month follow up survey following the ER class.
Pilot data on clinical outcomes to estimate effect sizes and inform power calculations for a fully powered randomized trial. These measures will be collected using a series of verified survey questionnaires.
Time frame: Data collected at the 1-, 2-, and 3-month follow up survey following the ER class.
Pilot data on clinical outcomes to estimate effect sizes and inform power calculations for a fully powered randomized trial. These measures will be collected using a series of verified survey questionnaires.
Contact information is provided by the study sponsor or research team.
University of Oklahoma
Other
Acronym: ejames3
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02995434
Agnosia, Cancer
Surrey, British Columbia, Canada
View Trial DetailsNCT02758197
Cancer, Chronic Pain
Ottawa, Ontario, Canada
View Trial DetailsNCT00374751
Agnosia, Cancer
Brooklyn, New York, United States
View Trial DetailsNCT01926444
Agnosia, Cancer
Scottsdale, Arizona, United States
View Trial Details